Literature DB >> 27623345

A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.

Isolde Schuster1, Marc Mertens1, Bernd Köllner2, Tomáš Korytář2, Markus Keller1, Bärbel Hammerschmidt3, Thomas Müller4, Noël Tordo5, Philippe Marianneau6, Claudia Mroz1, Melanie Rissmann1, Eileen Stroh1, Lisa Dähnert1, Felicitas Hammerschmidt7, Rainer G Ulrich1, Martin H Groschup8.   

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) circulates in many countries of Asia, Africa, and Europe. CCHFV can cause a severe hemorrhagic fever in humans with case-fatality rates of up to 80%. CCHF is considered to be one of the major emerging diseases spreading to and within Europe. Ticks of the genus Hyalomma function as vector as well as natural reservoir of CCHFV. Ticks feed on various domestic animals (e.g. cattle, sheep, goats) and on wildlife (e.g. hares, hedgehogs). Those animal species play an important role in the life cycle of the ticks as well as in amplification of CCHFV. Here we present a competitive ELISA (cELISA) for the species-independent detection of CCHFV-specific antibodies. For this purpose nucleocapsid (N) protein specific monoclonal antibodies (mAbs) were generated against an Escherichia coli (E. coli) expressed CCHFV N-protein. Thirty-three mAbs reacted with homologous and heterologous recombinant CCHFV antigens in ELISA and Western blot test and 20 of those 33 mAbs reacted additionally in an immunofluorescence assay with eukaryotic cells expressing the N-protein. Ten mAbs were further characterized in a prototype of the cELISA and nine of them competed with positive control sera of bovine origin. The cELISA was established by using the mAb with the strongest competition. For the validation, 833 sera from 12 animal species and from humans were used. The diagnostic sensitivity and specificity of the cELISA was determined to be 95% and 99%, respectively, and 2% of the sera gave inconclusive results. This cELISA offers the possibility for future large-scale screening approaches in various animal species to evaluate their susceptibility to CCHFV infection and to identify and monitor the occurrence of CCHFV.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amplifying hosts; CCHFV; Competitive ELISA; Crimean-Congo hemorrhagic fever; Monoclonal antibody; Nucleocapsid protein

Mesh:

Substances:

Year:  2016        PMID: 27623345     DOI: 10.1016/j.antiviral.2016.09.004

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  6 in total

1.  Second International Conference on Crimean-Congo Hemorrhagic Fever.

Authors:  Jessica R Spengler; Dennis A Bente; Mike Bray; Felicity Burt; Roger Hewson; Gülay Korukluoglu; Ali Mirazimi; Friedemann Weber; Anna Papa
Journal:  Antiviral Res       Date:  2017-12-02       Impact factor: 5.970

Review 2.  Crimean-Congo hemorrhagic fever and expansion from endemic regions.

Authors:  Jessica R Spengler; Éric Bergeron; Christina F Spiropoulou
Journal:  Curr Opin Virol       Date:  2019-01-16       Impact factor: 7.090

Review 3.  Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks.

Authors:  Barbara Bartolini; Cesare Em Gruber; Marion Koopmans; Tatjana Avšič; Sylvia Bino; Iva Christova; Roland Grunow; Roger Hewson; Gulay Korukluoglu; Cinthia Menel Lemos; Ali Mirazimi; Anna Papa; Maria Paz Sanchez-Seco; Aisha V Sauer; Hervè Zeller; Carla Nisii; Maria Rosaria Capobianchi; Giuseppe Ippolito; Chantal B Reusken; Antonino Di Caro
Journal:  Euro Surveill       Date:  2019-01

4.  Presence of antibodies to Crimean Congo haemorrhagic fever virus in sheep in Tunisia, North Africa.

Authors:  Médiha Khamassi Khbou; Rihab Romdhane; Faten Bouaicha Zaafouri; Mohsen Bouajila; Limam Sassi; Sofia K Appelberg; Ansgar Schulz; Ali Mirazimi; Martin H Groschup; Mourad Rekik; M'hammed Benzarti; Mohamed Gharbi
Journal:  Vet Med Sci       Date:  2021-08-14

5.  Development of Multispecies Recombinant Nucleoprotein-Based Indirect ELISA for High-Throughput Screening of Crimean-Congo Hemorrhagic Fever Virus-Specific Antibodies.

Authors:  Neha Shrivastava; Ambuj Shrivastava; Sandeep M Ninawe; Shashi Sharma; Jyoti S Kumar; Syed Imteyaz Alam; Amit Kanani; Sushil Kumar Sharma; Paban Kumar Dash
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

6.  Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies.

Authors:  Sultan Gülce-İz; Nazif Elaldı; Hüseyin Can; Esra Atalay Şahar; Muhammet Karakavuk; Aytül Gül; Gizem Örs Kumoğlu; Aysu Değirmenci Döşkaya; Adnan Yüksel Gürüz; Aykut Özdarendeli; Philip Louis Felgner; Huw Davies; Mert Döşkaya
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.